The potential for biosimilars in cell and gene therapy is being explored. Some companies, such as Celltrion, are expanding their businesses in this area, while others are discussing process development and production methods for biotherapies. The development of cell and gene therapies is seen as an opportunity to address unmet medical needs, with some countries, including India, emerging as key players in this field.